Parkman Healthcare Partners
Latest statistics and disclosures from Parkman Healthcare Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IRTC, UTHR, UNH, SGEN, IMUX, and represent 19.70% of Parkman Healthcare Partners's stock portfolio.
- Added to shares of these 10 stocks: THC (+$8.5M), IRTC (+$6.6M), NBIX (+$5.9M), SRRA, TFX, LEGN, MASS, ATEC, CDMO, CTLT.
- Started 15 new stock positions in ALLK, ATRC, MIRM, TFX, SRRA, LNDC, EIGR, PSTV, LNTH, RCKT. MASS, LEGN, CTIC, CNCE, NBIX.
- Reduced shares in these 10 stocks: , , HZNP (-$11M), DXCM (-$10M), AVTR (-$8.4M), DHR (-$6.4M), UNH (-$6.4M), ACRS (-$6.2M), IQV (-$5.3M), CVS.
- Sold out of its positions in ANGO, AZTA, Castlight Health, XRAY, ETNB, HCA, HALO, ICAD, IONS, KOD. ONCT, QTRX, RPID, RGEN, XBI, SMLR, STXS, VERA, HZNP.
- Parkman Healthcare Partners was a net seller of stock by $-70M.
- Parkman Healthcare Partners has $342M in assets under management (AUM), dropping by -24.60%.
- Central Index Key (CIK): 0001777015
Tip: Access up to 7 years of quarterly data
Positions held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Parkman Healthcare Partners
Companies in the Parkman Healthcare Partners portfolio as of the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Irhythm Technologies (IRTC) | 4.8 | $16M | +67% | 104k | 157.47 | |
| United Therapeutics Corporation (UTHR) | 3.9 | $13M | -17% | 74k | 179.42 | |
| UnitedHealth (UNH) | 3.8 | $13M | -33% | 25k | 509.97 | |
| Seagen (SGEN) | 3.6 | $12M | +6% | 86k | 144.05 | |
| Immunic (IMUX) | 3.6 | $12M | +11% | 1.1M | 11.30 | |
| Tenet Healthcare Corp Com New (THC) | 3.5 | $12M | +247% | 139k | 85.96 | |
| Iqvia Holdings (IQV) | 3.4 | $12M | -31% | 50k | 231.20 | |
| Aclaris Therapeutics (ACRS) | 3.4 | $12M | -34% | 668k | 17.24 | |
| Danaher Corporation (DHR) | 3.2 | $11M | -37% | 37k | 293.33 | |
| Xenon Pharmaceuticals (XENE) | 2.7 | $9.3M | -15% | 304k | 30.57 | |
| R1 Rcm (RCM) | 2.7 | $9.2M | +14% | 343k | 26.76 | |
| Alnylam Pharmaceuticals (ALNY) | 2.6 | $8.8M | -6% | 54k | 163.29 | |
| Catalent (CTLT) | 2.6 | $8.8M | +29% | 79k | 110.91 | |
| CVS Caremark Corporation (CVS) | 2.5 | $8.7M | -35% | 86k | 101.21 | |
Setup an alertParkman Healthcare Partners will file the next quarterly 13-HR in about 3 months. Would you like to be notified? |
||||||
| Peregrine Pharmaceuticals (CDMO) | 2.4 | $8.3M | +40% | 408k | 20.37 | |
| Cooper Cos Com New (COO) | 2.4 | $8.2M | -17% | 20k | 417.62 | |
| BioCryst Pharmaceuticals (BCRX) | 2.3 | $7.8M | +19% | 477k | 16.26 | |
| Abbvie (ABBV) | 2.2 | $7.4M | -11% | 46k | 162.10 | |
| Dex (DXCM) | 1.9 | $6.5M | -61% | 13k | 511.58 | |
| Neurocrine Biosciences (NBIX) | 1.7 | $5.9M | NEW | 63k | 93.75 | |
| Codexis (CDXS) | 1.6 | $5.5M | -21% | 268k | 20.62 | |
| Avantor (AVTR) | 1.6 | $5.4M | -61% | 158k | 33.82 | |
| Natera (NTRA) | 1.5 | $5.3M | +4% | 130k | 40.68 | |
| Arcus Biosciences Incorporated (RCUS) | 1.5 | $5.3M | +42% | 167k | 31.56 | |
| Alphatec Hldgs Com New (ATEC) | 1.5 | $5.2M | +92% | 452k | 11.50 | |
| IDEXX Laboratories (IDXX) | 1.5 | $5.1M | -14% | 9.4k | 547.08 | |
| Apollo Endosurgery (APEN) | 1.4 | $4.9M | -11% | 810k | 6.05 | |
| Sierra Oncology Com New (SRRA) | 1.4 | $4.9M | NEW | 152k | 32.05 | |
| Teleflex Incorporated (TFX) | 1.3 | $4.4M | NEW | 13k | 354.80 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.3 | $4.4M | NEW | 121k | 36.34 | |
| Schrodinger (SDGR) | 1.2 | $4.0M | +70% | 116k | 34.12 | |
| Keros Therapeutics (KROS) | 1.2 | $4.0M | +4% | 73k | 54.38 | |
| Harvard Bioscience (HBIO) | 1.2 | $3.9M | +18% | 634k | 6.21 | |
| Fulcrum Therapeutics (FULC) | 1.1 | $3.9M | -34% | 165k | 23.65 | |
| Outset Med (OM) | 1.1 | $3.7M | +72% | 82k | 45.40 | |
| Supernus Pharmaceuticals (SUPN) | 1.0 | $3.5M | +4% | 109k | 32.32 | |
| Insulet Corporation (PODD) | 1.0 | $3.4M | -25% | 13k | 266.36 | |
| 908 Devices (MASS) | 1.0 | $3.3M | NEW | 175k | 19.01 | |
| Biosante Pharmaceuticals (ANIP) | 0.9 | $3.0M | -21% | 108k | 28.11 | |
| Performant Finl (PFMT) | 0.9 | $3.0M | +12% | 957k | 3.11 | |
| Charles River Laboratories (CRL) | 0.8 | $2.8M | -61% | 10k | 284.00 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.8 | $2.7M | -21% | 77k | 35.28 | |
| Imago Biosciences (IMGO) | 0.8 | $2.7M | +27% | 140k | 19.27 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.7 | $2.5M | -11% | 57k | 43.88 | |
| Mannkind Corp Com New (MNKD) | 0.7 | $2.5M | +154% | 675k | 3.68 | |
| Health Catalyst (HCAT) | 0.6 | $2.1M | +51% | 80k | 26.13 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $2.0M | -29% | 20k | 98.12 | |
| Repro-Med Systems (KRMD) | 0.6 | $1.9M | +12% | 673k | 2.86 | |
| Altimmune Com New (ALT) | 0.6 | $1.9M | +17% | 310k | 6.09 | |
| Gossamer Bio (GOSS) | 0.5 | $1.7M | -63% | 200k | 8.68 | |
| Veracyte (VCYT) | 0.5 | $1.7M | -2% | 61k | 27.57 | |
| AtriCure (ATRC) | 0.5 | $1.7M | NEW | 25k | 65.66 | |
| Akoya Biosciences (AKYA) | 0.5 | $1.7M | +20% | 150k | 10.99 | |
| Alpha Teknova (TKNO) | 0.5 | $1.6M | +13% | 120k | 13.81 | |
| Sutro Biopharma (STRO) | 0.5 | $1.6M | -9% | 200k | 8.22 | |
| Plus Therapeutics Com New (PSTV) | 0.4 | $1.5M | NEW | 1.5M | 1.00 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.4 | $1.4M | NEW | 25k | 55.31 | |
| Landec Corporation (LNDC) | 0.4 | $1.3M | NEW | 115k | 11.58 | |
| Concert Pharmaceuticals I equity (CNCE) | 0.4 | $1.3M | NEW | 377k | 3.37 | |
| Tela Bio (TELA) | 0.4 | $1.3M | +4% | 109k | 11.63 | |
| Mirati Therapeutics (MRTX) | 0.4 | $1.3M | +17% | 15k | 82.24 | |
| Recro Pharma (SCTL) | 0.4 | $1.2M | +4% | 672k | 1.80 | |
| Sientra (SIEN) | 0.3 | $1.2M | +8% | 532k | 2.22 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.3 | $1.2M | +4% | 118k | 9.94 | |
| Forma Therapeutics Hldgs SHS (FMTX) | 0.3 | $1.2M | +24% | 124k | 9.30 | |
| Cti Biopharma (CTIC) | 0.3 | $1.1M | NEW | 225k | 4.67 | |
| Axogen (AXGN) | 0.3 | $1.0M | -37% | 129k | 7.94 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $922k | +4% | 37k | 24.73 | |
| Phathom Pharmaceuticals (PHAT) | 0.3 | $892k | -15% | 66k | 13.61 | |
| Allakos (ALLK) | 0.3 | $867k | NEW | 152k | 5.70 | |
| Zymeworks (ZYME) | 0.2 | $781k | +186% | 119k | 6.55 | |
| Opiant Pharmaceuticals (OPNT) | 0.2 | $697k | +4% | 33k | 21.41 | |
| Mirum Pharmaceuticals (MIRM) | 0.2 | $668k | NEW | 30k | 22.01 | |
| Surface Oncology (SURF) | 0.2 | $615k | -19% | 209k | 2.94 | |
| Biolinerx Sponsored Ads (BLRX) | 0.1 | $463k | -36% | 271k | 1.71 | |
| Eiger Biopharmaceuticals (EIGR) | 0.1 | $415k | NEW | 50k | 8.30 | |
| Rocket Pharmaceuticals (RCKT) | 0.1 | $401k | NEW | 25k | 15.85 | |
| Molecular Templates (MTEM) | 0.1 | $358k | -29% | 104k | 3.45 | |
| Nurix Therapeutics (NRIX) | 0.1 | $289k | -76% | 21k | 13.99 | |
| Verastem (VSTM) | 0.1 | $269k | +4% | 191k | 1.41 | |
Past Filings by Parkman Healthcare Partners
SEC 13F filings are viewable for Parkman Healthcare Partners going back to 2019
- Parkman Healthcare Partners 2022 Q1 filed May 13, 2022
- Parkman Healthcare Partners 2021 Q4 filed Feb. 11, 2022
- Parkman Healthcare Partners 2021 Q3 filed Nov. 12, 2021
- Parkman Healthcare Partners 2021 Q2 filed Aug. 13, 2021
- Parkman Healthcare Partners 2021 Q1 filed May 14, 2021
- Parkman Healthcare Partners 2020 Q4 filed Feb. 12, 2021
- Parkman Healthcare Partners 2020 Q3 filed Nov. 13, 2020
- Parkman Healthcare Partners 2020 Q2 filed Aug. 13, 2020
- Parkman Healthcare Partners 2020 Q1 filed May 15, 2020
- Parkman Healthcare Partners 2019 Q4 filed Feb. 13, 2020